RTI and Aziyo Partner on ViBone Cellular Matrix

By Julie A. Vetalice

Aziyo Biologics will provide ViBone® cellular bone matrix to RTI Surgical for exclusive distribution in the U.S. Further, the companies will partner on new research for the product.

ViBone is a next-gen viable bone matrix designed to perform like high-quality autograft. ViBone is processed using a proprietary method designed to protect and preserve the health of native bone cells, thus potentially enhancing new bone formation.

Source: Aziyo Biologics, Inc. and RTI Surgical, Inc.

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: M&A